Mnk earmarks eIF4E for cancer therapy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 32, 2010, Pages 13975-13976

  Hay, Nissim ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; INITIATION FACTOR 4E; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATING PROTEIN KINASE INTERACTING KINASE 1; MITOGEN ACTIVATING PROTEIN KINASE INTERACTING KINASE 2; MITOGEN ACTIVATING PROTEIN KINASE INTERACTING KINASE INHIBITOR; PHOSPHOTRANSFERASE; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE; ATP7A PROTEIN, HUMAN; CATION TRANSPORT PROTEIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER THERAPY; CARCINOGENESIS; DROSOPHILA; FEEDBACK SYSTEM; HUMAN; MAMMAL; MOUSE; NEOPLASM; NONHUMAN; NOTE; PHOSPHORYLATION; PRIORITY JOURNAL; ANIMAL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CATION TRANSPORT PROTEINS; EUKARYOTIC INITIATION FACTOR-4E; HUMANS; NEOPLASMS; PHOSPHORYLATION;

EID: 77956275194     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1008908107     Document Type: Note

References (13)

1. Bhaskar PT, Hay N (2007) The two TORCs and Akt. Dev Cell 12:487-502.
2. Furic L, et al. (2010) eIF4E phosphorylation promotes tumorigenesisandis associatedwith prostate cancer progression. Proc Natl Acad Sci USA 107:14134-14139.
3. Ueda T, et al. (2010) Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development. Proc Natl Acad Sci USA 107:13984-13990.
4. Skeen JE, et al. (2006) Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell 10:269-280.
5. Sonenberg N (2008) eIF4E, the mRNA cap-binding protein: From basic discovery to translational research. Biochem Cell Biol 86:178-183.
6. Dowling RJ, et al. (2010) mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4EBPs. Science 328:1172-1176.
7. Scheper GC, Proud CG (2002) Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? Eur J Biochem 269:5350-5359.
8. Pyronnet S, et al. (1999) Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J 18:270-279.
9. Lachance PE, Miron M, Raught B, Sonenberg N, Lasko P (2002) Phosphorylation of eukaryotic translation initiation factor 4E is critical for growth. Mol Cell Biol 22:1656-1663. (Pubitemid 34174983)
10. Wendel HG, et al. (2007) Dissecting eIF4E action in tumorigenesis. Genes Dev 21:3232-3237.
11. Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S, Fukunaga R (2004)Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol 24:6539-6549. (Pubitemid 38944335)
12. Culjkovic B, Topisirovic I, Borden KL (2007) Controlling gene expression through RNA regulons: The role of the eukaryotic translation initiation factor eIF4E. Cell Cycle 6:65-69. (Pubitemid 46173883)
13. Bhaskar PT, et al. (2009) mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition. Mol Cell Biol 29:5136-5147.